Biologic Drugs With Established Pharmaceutical Class: Interleukin-5 Antagonist
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Interleukin-5 Antagonist
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | ⤷ Start Trial | ⤷ Start Trial |
| Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | 10,870,695 | ⤷ Start Trial |
| Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | 5,693,323 | ⤷ Start Trial |
| Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | 6,129,913 | ⤷ Start Trial |
| Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | 1,087,069,510,870,695 | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
